Age variation and sexual dimorphism in the sixteen diagnostic clusters of risk factors for the metabolic syndrome

Autor: Roy T. Sabo, Silva S Arslanian, Cynthia Shier Sabo, Ruishan Wu, Shumei S. Sun

Publikováno v: Zeitschrift Fur Gesundheitswissenschaften

OBJECTIVE: To document age- and sex-related differences in the 16 phenotypes of risk factors for the metabolic syndrome (MS) among adults in the Fels Longitudinal Study (FLS). METHODS: Data on risk factors for the MS were analyzed in 471 white men an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72607c5fd862e24a4ad5542ff7b7c6f7
https://doi.org/10.1007/s10389-012-0490-2

Liraglutide for Children 6 to <12 Years of Age with Obesity - A Randomized Trial.

Autor: Fox CK; From the Center for Pediatric Obesity Medicine (C.K.F., E.M.B.) and the Division of Endocrinology (E.M.B.), Department of Pediatrics, University of Minnesota Medical School, Minneapolis; Pediatric Endocrinology, Hospital Ángeles Puebla, Puebla City, Mexico (M.B.-P.); Novo Nordisk Global Business Services, Bangalore, India (J.D., K.S.); the Division of Pediatric Endocrinology, Department of Pediatrics, Universitair Ziekenhuis Brussel, Brussels (I.G.); Novo Nordisk, Søborg, Denmark (N.M.H.-L., P.W.); the Department of Paediatrics, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (M.Y.J.); the Department of Endocrinology, Diabetes and Metabolic Diseases, Kantonsspital Olten, Olten, and the Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital, University of Bern, Bern - both in Switzerland (T.Z.); and the Center for Pediatric Research in Obesity and Metabolism, Division of Pediatric Endocrinology, Metabolism, and Diabetes Mellitus, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh (S.A.)., Barrientos-Pérez M; From the Center for Pediatric Obesity Medicine (C.K.F., E.M.B.) and the Division of Endocrinology (E.M.B.), Department of Pediatrics, University of Minnesota Medical School, Minneapolis; Pediatric Endocrinology, Hospital Ángeles Puebla, Puebla City, Mexico (M.B.-P.); Novo Nordisk Global Business Services, Bangalore, India (J.D., K.S.); the Division of Pediatric Endocrinology, Department of Pediatrics, Universitair Ziekenhuis Brussel, Brussels (I.G.); Novo Nordisk, Søborg, Denmark (N.M.H.-L., P.W.); the Department of Paediatrics, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (M.Y.J.); the Department of Endocrinology, Diabetes and Metabolic Diseases, Kantonsspital Olten, Olten, and the Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital, University of Bern, Bern - both in Switzerland (T.Z.); and the Center for Pediatric Research in Obesity and Metabolism, Division of Pediatric Endocrinology, Metabolism, and Diabetes Mellitus, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh (S.A.)., Bomberg EM; From the Center for Pediatric Obesity Medicine (C.K.F., E.M.B.) and the Division of Endocrinology (E.M.B.), Department of Pediatrics, University of Minnesota Medical School, Minneapolis; Pediatric Endocrinology, Hospital Ángeles Puebla, Puebla City, Mexico (M.B.-P.); Novo Nordisk Global Business Services, Bangalore, India (J.D., K.S.); the Division of Pediatric Endocrinology, Department of Pediatrics, Universitair Ziekenhuis Brussel, Brussels (I.G.); Novo Nordisk, Søborg, Denmark (N.M.H.-L., P.W.); the Department of Paediatrics, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (M.Y.J.); the Department of Endocrinology, Diabetes and Metabolic Diseases, Kantonsspital Olten, Olten, and the Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital, University of Bern, Bern - both in Switzerland (T.Z.); and the Center for Pediatric Research in Obesity and Metabolism, Division of Pediatric Endocrinology, Metabolism, and Diabetes Mellitus, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh (S.A.)., Dcruz J; From the Center for Pediatric Obesity Medicine (C.K.F., E.M.B.) and the Division of Endocrinology (E.M.B.), Department of Pediatrics, University of Minnesota Medical School, Minneapolis; Pediatric Endocrinology, Hospital Ángeles Puebla, Puebla City, Mexico (M.B.-P.); Novo Nordisk Global Business Services, Bangalore, India (J.D., K.S.); the Division of Pediatric Endocrinology, Department of Pediatrics, Universitair Ziekenhuis Brussel, Brussels (I.G.); Novo Nordisk, Søborg, Denmark (N.M.H.-L., P.W.); the Department of Paediatrics, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (M.Y.J.); the Department of Endocrinology, Diabetes and Metabolic Diseases, Kantonsspital Olten, Olten, and the Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital, University of Bern, Bern - both in Switzerland (T.Z.); and the Center for Pediatric Research in Obesity and Metabolism, Division of Pediatric Endocrinology, Metabolism, and Diabetes Mellitus, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh (S.A.)., Gies I; From the Center for Pediatric Obesity Medicine (C.K.F., E.M.B.) and the Division of Endocrinology (E.M.B.), Department of Pediatrics, University of Minnesota Medical School, Minneapolis; Pediatric Endocrinology, Hospital Ángeles Puebla, Puebla City, Mexico (M.B.-P.); Novo Nordisk Global Business Services, Bangalore, India (J.D., K.S.); the Division of Pediatric Endocrinology, Department of Pediatrics, Universitair Ziekenhuis Brussel, Brussels (I.G.); Novo Nordisk, Søborg, Denmark (N.M.H.-L., P.W.); the Department of Paediatrics, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (M.Y.J.); the Department of Endocrinology, Diabetes and Metabolic Diseases, Kantonsspital Olten, Olten, and the Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital, University of Bern, Bern - both in Switzerland (T.Z.); and the Center for Pediatric Research in Obesity and Metabolism, Division of Pediatric Endocrinology, Metabolism, and Diabetes Mellitus, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh (S.A.)., Harder-Lauridsen NM; From the Center for Pediatric Obesity Medicine (C.K.F., E.M.B.) and the Division of Endocrinology (E.M.B.), Department of Pediatrics, University of Minnesota Medical School, Minneapolis; Pediatric Endocrinology, Hospital Ángeles Puebla, Puebla City, Mexico (M.B.-P.); Novo Nordisk Global Business Services, Bangalore, India (J.D., K.S.); the Division of Pediatric Endocrinology, Department of Pediatrics, Universitair Ziekenhuis Brussel, Brussels (I.G.); Novo Nordisk, Søborg, Denmark (N.M.H.-L., P.W.); the Department of Paediatrics, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (M.Y.J.); the Department of Endocrinology, Diabetes and Metabolic Diseases, Kantonsspital Olten, Olten, and the Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital, University of Bern, Bern - both in Switzerland (T.Z.); and the Center for Pediatric Research in Obesity and Metabolism, Division of Pediatric Endocrinology, Metabolism, and Diabetes Mellitus, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh (S.A.)., Jalaludin MY; From the Center for Pediatric Obesity Medicine (C.K.F., E.M.B.) and the Division of Endocrinology (E.M.B.), Department of Pediatrics, University of Minnesota Medical School, Minneapolis; Pediatric Endocrinology, Hospital Ángeles Puebla, Puebla City, Mexico (M.B.-P.); Novo Nordisk Global Business Services, Bangalore, India (J.D., K.S.); the Division of Pediatric Endocrinology, Department of Pediatrics, Universitair Ziekenhuis Brussel, Brussels (I.G.); Novo Nordisk, Søborg, Denmark (N.M.H.-L., P.W.); the Department of Paediatrics, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (M.Y.J.); the Department of Endocrinology, Diabetes and Metabolic Diseases, Kantonsspital Olten, Olten, and the Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital, University of Bern, Bern - both in Switzerland (T.Z.); and the Center for Pediatric Research in Obesity and Metabolism, Division of Pediatric Endocrinology, Metabolism, and Diabetes Mellitus, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh (S.A.)., Sahu K; From the Center for Pediatric Obesity Medicine (C.K.F., E.M.B.) and the Division of Endocrinology (E.M.B.), Department of Pediatrics, University of Minnesota Medical School, Minneapolis; Pediatric Endocrinology, Hospital Ángeles Puebla, Puebla City, Mexico (M.B.-P.); Novo Nordisk Global Business Services, Bangalore, India (J.D., K.S.); the Division of Pediatric Endocrinology, Department of Pediatrics, Universitair Ziekenhuis Brussel, Brussels (I.G.); Novo Nordisk, Søborg, Denmark (N.M.H.-L., P.W.); the Department of Paediatrics, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (M.Y.J.); the Department of Endocrinology, Diabetes and Metabolic Diseases, Kantonsspital Olten, Olten, and the Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital, University of Bern, Bern - both in Switzerland (T.Z.); and the Center for Pediatric Research in Obesity and Metabolism, Division of Pediatric Endocrinology, Metabolism, and Diabetes Mellitus, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh (S.A.)., Weimers P; From the Center for Pediatric Obesity Medicine (C.K.F., E.M.B.) and the Division of Endocrinology (E.M.B.), Department of Pediatrics, University of Minnesota Medical School, Minneapolis; Pediatric Endocrinology, Hospital Ángeles Puebla, Puebla City, Mexico (M.B.-P.); Novo Nordisk Global Business Services, Bangalore, India (J.D., K.S.); the Division of Pediatric Endocrinology, Department of Pediatrics, Universitair Ziekenhuis Brussel, Brussels (I.G.); Novo Nordisk, Søborg, Denmark (N.M.H.-L., P.W.); the Department of Paediatrics, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (M.Y.J.); the Department of Endocrinology, Diabetes and Metabolic Diseases, Kantonsspital Olten, Olten, and the Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital, University of Bern, Bern - both in Switzerland (T.Z.); and the Center for Pediatric Research in Obesity and Metabolism, Division of Pediatric Endocrinology, Metabolism, and Diabetes Mellitus, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh (S.A.)., Zueger T; From the Center for Pediatric Obesity Medicine (C.K.F., E.M.B.) and the Division of Endocrinology (E.M.B.), Department of Pediatrics, University of Minnesota Medical School, Minneapolis; Pediatric Endocrinology, Hospital Ángeles Puebla, Puebla City, Mexico (M.B.-P.); Novo Nordisk Global Business Services, Bangalore, India (J.D., K.S.); the Division of Pediatric Endocrinology, Department of Pediatrics, Universitair Ziekenhuis Brussel, Brussels (I.G.); Novo Nordisk, Søborg, Denmark (N.M.H.-L., P.W.); the Department of Paediatrics, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (M.Y.J.); the Department of Endocrinology, Diabetes and Metabolic Diseases, Kantonsspital Olten, Olten, and the Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital, University of Bern, Bern - both in Switzerland (T.Z.); and the Center for Pediatric Research in Obesity and Metabolism, Division of Pediatric Endocrinology, Metabolism, and Diabetes Mellitus, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh (S.A.)., Arslanian S; From the Center for Pediatric Obesity Medicine (C.K.F., E.M.B.) and the Division of Endocrinology (E.M.B.), Department of Pediatrics, University of Minnesota Medical School, Minneapolis; Pediatric Endocrinology, Hospital Ángeles Puebla, Puebla City, Mexico (M.B.-P.); Novo Nordisk Global Business Services, Bangalore, India (J.D., K.S.); the Division of Pediatric Endocrinology, Department of Pediatrics, Universitair Ziekenhuis Brussel, Brussels (I.G.); Novo Nordisk, Søborg, Denmark (N.M.H.-L., P.W.); the Department of Paediatrics, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (M.Y.J.); the Department of Endocrinology, Diabetes and Metabolic Diseases, Kantonsspital Olten, Olten, and the Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital, University of Bern, Bern - both in Switzerland (T.Z.); and the Center for Pediatric Research in Obesity and Metabolism, Division of Pediatric Endocrinology, Metabolism, and Diabetes Mellitus, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh (S.A.).

Publikováno v: The New England journal of medicine [N Engl J Med] 2024 Sep 10. Date of Electronic Publication: 2024 Sep 10.

Semaglutide for management of obesity in adolescents: efficacy, safety, and considerations for clinical practice.

Autor: Bensignor MO; Division of Pediatric Endocrinology and Diabetes, Center for Pediatric Obesity Medicine, University of Minnesota Medical School, Minneapolis, Minnesota; Division of Pediatric Endocrinology and Diabetes, University of Minnesota Medical School, Minneapolis, Minnesota., Arslanian S; Division of Pediatric Endocrinology, Diabetes, and Metabolism and Center for Pediatric Research in Obesity and Metabolism, UPMC Children's Hospital of Pittsburgh and University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Vajravelu ME; Division of Pediatric Endocrinology, Diabetes, and Metabolism and Center for Pediatric Research in Obesity and Metabolism, UPMC Children's Hospital of Pittsburgh and University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Publikováno v: Current opinion in pediatrics [Curr Opin Pediatr] 2024 Aug 01; Vol. 36 (4), pp. 449-455. Date of Electronic Publication: 2024 May 15.

Reproducibility of Glycemic Measures Among Dysglycemic Youth and Adults in the RISE Study.

Autor: Tjaden AH; The Biostatistics Center, Milken Institute School of Public Health The George Washington University, Rockville, MD, USA., Edelstein SL; The Biostatistics Center, Milken Institute School of Public Health The George Washington University, Rockville, MD, USA., Arslanian S; Division of Pediatric Endocrinology, Diabetes, and Metabolism, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, USA., Barengolts E; Department of Medicine, University of Illinois and Jesse Brown VA Medical Center, Chicago, IL, USA., Caprio S; Pediatric Endocrinology & Diabetes, Yale University School of Medicine, New Haven, CT, USA., Cree-Green M; Pediatric Endocrinology, University of Colorado Anschutz Medical Campus/Children's Hospital Colorado, Aurora, CO, USA., Lteif A; Division of Endocrinology and Metabolism, Indiana University School of Medicine and Roudebush VA Medical Center, Indianapolis, IN, USA., Mather KJ; Division of Endocrinology and Metabolism, Indiana University School of Medicine and Roudebush VA Medical Center, Indianapolis, IN, USA., Savoye M; Pediatric Endocrinology & Diabetes, Yale University School of Medicine, New Haven, CT, USA., Xiang AH; Department of Research & Evaluation, Kaiser Permanente Southern California, Los Angeles, CA, USA., Kahn SE; Division of Metabolism, Endocrinology and Nutrition, VA Puget Sound Health Care System and University of Washington, Seattle, WA, USA.

Publikováno v: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2023 Sep 18; Vol. 108 (10), pp. e1125-e1133.

Reducing BMI below the obesity threshold in adolescents treated with once-weekly subcutaneous semaglutide 2.4 mg.

Autor: Kelly AS; Department of Pediatrics and Center for Pediatric Obesity Medicine, University of Minnesota Medical School, Minneapolis, Minnesota, USA., Arslanian S; Division of Pediatric Endocrinology, Diabetes and Metabolism, Center for Pediatric Research in Obesity and Metabolism, University of Pittsburgh School of Medicine, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA., Hesse D; Novo Nordisk A/S, Søborg, Denmark., Iversen AT; Novo Nordisk A/S, Søborg, Denmark., Körner A; Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, Leipzig, Germany.; Center for Pediatric Research (CPL), Leipzig University, Medical Faculty, Hospital for Children and Adolescents, Leipzig, Germany., Schmidt S; Novo Nordisk A/S, Søborg, Denmark., Sørrig R; Novo Nordisk A/S, Søborg, Denmark., Weghuber D; Department of Pediatrics, Paracelsus Medical University, Salzburg, Austria., Jastreboff AM; Department of Medicine (Endocrinology and Metabolism) and Department of Pediatrics (Pediatric Endocrinology), Yale University School of Medicine, New Haven, Connecticut, USA.

Publikováno v: Obesity (Silver Spring, Md.) [Obesity (Silver Spring)] 2023 Aug; Vol. 31 (8), pp. 2139-2149. Date of Electronic Publication: 2023 Jul 09.